This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Omoto E, Deguchi S, Takaba S, Kojima K, Yano T, Katayama Y, Sunami K, Takeuchi M, Kimura F, Harada M, Kimura I . Low-dose melphalan for treatment of high-risk myelodysplastic syndromes Leukemia 1996 10: 609–614
Denzlinger C, Bowen D, Benz D, Gelly K, Brugger W, Kanz L . Low-dose melphalan induces favourable responses in elderly patients with high risk myelodysplastic syndromes or secondary acute myeloid leukaemia Br J Haematol 2000 108: 93–95
Sandberg A, Abe S, Kowalczyk J, Zedgenidze A, Takeuchi J, Kakati S . Chromosomes and causation of human cancer and leukaemia. I. Cytogenetics of leukaemias complicating other diseases Cancer Genet Cytogenet 1982 7: 95–136
Merlat A, Lai H, Sterkers Y, Demory H, Bauters F, Preudhomme C, Fenaux P . Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases Leukemia 1999 13: 250–257
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kerr, R., Cunningham, J. & Bowen, D. Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes. Leukemia 14, 953 (2000). https://doi.org/10.1038/sj.leu.2401762
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401762